Needham analyst Michael Matson reiterated a Buy rating on NeoGenomics (NEO – Research Report) today and set a price target of $19.00.Stay Ahead ...

NeoGenomics (NASDAQ:NEO) shares popped ~4% premarket on Wednesday after the oncology testing services company set a revenue ...

One Power, an industrial power company, announced it has appointed Eileen Fargis as its chief financial officer. Ms. Fargis’ brings leadership and financial knowledge as well as company expertise from ...

NeoGenomics, Inc. ("NeoGenomics" or the "Company") , a leading oncology testing services company, today provided financial guidance for fiscal year 2025 and updated its Long-Range Financial Plan. "We ...

The company said, “The Long-Range Plan builds upon the successful execution of the previous three years. NeoGenomics (NEO) intends to achieve ...

NeoGenomics (NEO) shares ended the last trading session 9.1% higher at $13.78. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This ...

The financial sector in the United States is undergoing a significant transformation, driven by the emergence of neobanks and ...

The Magnus Neo represents the evolution of Ampere's Magnus EX and is set to deliver more style, more power, more strength, more safety, and more savings. The Magnus Neo will take center stage at Auto ...

Known for her commitment to championing Southeast Asian contemporary art, Singaporean art collector Linda Neo, together with ...

NeoGenomics (NASDAQ:NEO – Get Free Report)‘s stock had its “buy” rating reaffirmed by investment analysts at Needham & Company LLC in a note issued to investors on Friday,Benzinga reports. They ...

MoneyShow presents top investment ideas for 2024 from leading advisors. Part 2 includes Neo Performance Metals, Fannie Mae, ...

Neo Asset Management, founded in 2021 and backed by venture company Peak XV Partners as well as Japanese financial group MUFG ...